rosiglitazone has been researched along with Libman-Sacks Disease in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Altamirano-Lagos, MJ; Fernández-Fierro, A; Funes, SC; Gómez-Santander, F; Jara, EL; Kalergis, AM; Mackern-Oberti, JP; Pulgar-Sepúlveda, R; Rebolledo-Zelada, D; Ríos, M; Rivera-Perez, D; Roa, JC; Villarroel, A | 1 |
| Choi, ET; Hu, W; Nanayakkara, GK; Shao, Y; Wang, H; Xu, K; Yang, F; Yang, WY; Yang, X | 1 |
| Aprahamian, TR; Bonegio, RG; Gharakhanian, R; Rifkin, IR; Weitzner, Z | 1 |
| Barrientos, MJ; Bueno, SM; González, PA; Gutiérrez, MA; Herrada, AA; Iruretagoyena, MI; Jacobelli, SH; Kalergis, AM; Leiva, ED; Riedel, CA | 1 |
| Aprahamian, T; Bonegio, RG; Chiang, LK; Richez, C; Rifkin, IR; Sato, K; Walsh, K; Yasuda, K | 1 |
| Glover, PH; Jones, AV; Maric, C; McLemore, GR; Racusen, LC; Reckelhoff, JF; Ryan, MJ; Sartori-Valinotti, JC; Venegas-Pont, M | 1 |
6 other study(ies) available for rosiglitazone and Libman-Sacks Disease
| Article | Year |
|---|---|
Tolerogenic dendritic cell transfer ameliorates systemic lupus erythematosus in mice.
Topics: Animals; Antibodies, Antinuclear; Cell Differentiation; Cells, Cultured; Dendritic Cells; Dexamethasone; Disease Models, Animal; Humans; Immune Tolerance; Immunotherapy, Adoptive; Kidney; Lupus Erythematosus, Systemic; Lymphocyte Activation; Mice; Mice, Inbred MRL lpr; Pyrazines; Pyrroles; Rosiglitazone; T-Lymphocytes, Regulatory | 2019 |
GATA3, HDAC6, and BCL6 Regulate FOXP3+ Treg Plasticity and Determine Treg Conversion into Either Novel Antigen-Presenting Cell-Like Treg or Th1-Treg.
Topics: Animals; Antigen-Presenting Cells; Aorta; Cell Plasticity; Endothelial Cells; GATA3 Transcription Factor; Histone Deacetylase 6; Humans; Insulin Resistance; Lupus Erythematosus, Systemic; Lymphocyte Activation; Mice; Mice, Knockout, ApoE; Proto-Oncogene Proteins c-bcl-6; Psoriasis; Rosiglitazone; T-Lymphocytes, Regulatory; Th1 Cells | 2018 |
Peroxisome proliferator-activated receptor gamma agonists in the prevention and treatment of murine systemic lupus erythematosus.
Topics: Animals; Apolipoproteins E; Lupus Erythematosus, Systemic; Mice; Mice, Inbred C57BL; Mice, Knockout; Pioglitazone; PPAR gamma; Rosiglitazone; Thiazolidinediones | 2014 |
Modulation of nuclear factor-kappaB activity can influence the susceptibility to systemic lupus erythematosus.
Topics: Animals; Anti-Inflammatory Agents; Dendritic Cells; Diterpenes; Female; Glomerulonephritis; Hypoglycemic Agents; I-kappa B Proteins; Lupus Erythematosus, Systemic; Mice; Mice, Inbred C57BL; Mice, Knockout; NF-kappa B; Receptors, IgG; Rosiglitazone; Thiazolidinediones | 2009 |
The peroxisome proliferator-activated receptor gamma agonist rosiglitazone ameliorates murine lupus by induction of adiponectin.
Topics: Adiponectin; Animals; Atherosclerosis; Disease Models, Animal; Female; Inflammation Mediators; Lupus Erythematosus, Systemic; Male; Mice; Mice, Inbred C57BL; Mice, Inbred MRL lpr; Mice, Knockout; PPAR gamma; Rosiglitazone; Thiazolidinediones | 2009 |
Rosiglitazone decreases blood pressure and renal injury in a female mouse model of systemic lupus erythematosus.
Topics: Albuminuria; Animals; Antihypertensive Agents; Blood Pressure; Chemokine CCL2; Disease Models, Animal; Endothelin-1; Female; Hypertension; Kidney; Kidney Diseases; Lupus Erythematosus, Systemic; Macrophages; Mice; Monocytes; Osteopontin; PPAR gamma; RNA, Messenger; Rosiglitazone; Thiazolidinediones | 2009 |